nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—PSMB1—Disease—BGN—osteoarthritis	0.000497	0.000497	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CAMK2B—osteoarthritis	0.000495	0.000495	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CTSK—osteoarthritis	0.000495	0.000495	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CAMK2B—osteoarthritis	0.000495	0.000495	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CTSK—osteoarthritis	0.000495	0.000495	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CAMK2B—osteoarthritis	0.000495	0.000495	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CTSK—osteoarthritis	0.000495	0.000495	CbGpPWpGaD
Bortezomib—PSMB8—Disease—BGN—osteoarthritis	0.00049	0.00049	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CTSK—osteoarthritis	0.000488	0.000488	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CAMK2B—osteoarthritis	0.000488	0.000488	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—osteoarthritis	0.000472	0.000472	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000463	0.000463	CbGpPWpGaD
Bortezomib—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	0.000456	0.000456	CbGpPWpGaD
Bortezomib—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	0.000449	0.000449	CbGpPWpGaD
Bortezomib—CYP1A2—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000442	0.000442	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.000439	0.000439	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—IL1B—osteoarthritis	0.000435	0.000435	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—GSTO1—osteoarthritis	0.00043	0.00043	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—GSTO1—osteoarthritis	0.00043	0.00043	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—GSTO1—osteoarthritis	0.00043	0.00043	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—GSTO1—osteoarthritis	0.000424	0.000424	CbGpPWpGaD
Bortezomib—PTGS1—Selenium Micronutrient Network—TNF—osteoarthritis	0.000422	0.000422	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—BGN—osteoarthritis	0.000416	0.000416	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—BGN—osteoarthritis	0.000416	0.000416	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—BGN—osteoarthritis	0.000416	0.000416	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000413	0.000413	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—BGN—osteoarthritis	0.00041	0.00041	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—COL9A2—osteoarthritis	0.000409	0.000409	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—COL9A2—osteoarthritis	0.000409	0.000409	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—COL9A2—osteoarthritis	0.000409	0.000409	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—COL9A2—osteoarthritis	0.000404	0.000404	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—COL9A1—osteoarthritis	0.000397	0.000397	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—COL9A1—osteoarthritis	0.000397	0.000397	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—COL9A1—osteoarthritis	0.000397	0.000397	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—HSPA5—osteoarthritis	0.000394	0.000394	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—HSPA5—osteoarthritis	0.000394	0.000394	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—HSPA5—osteoarthritis	0.000394	0.000394	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—COL9A1—osteoarthritis	0.000392	0.000392	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—FMOD—osteoarthritis	0.000391	0.000391	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—HSPA5—osteoarthritis	0.000389	0.000389	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL1RN—osteoarthritis	0.000384	0.000384	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IL1RN—osteoarthritis	0.000384	0.000384	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IL1RN—osteoarthritis	0.000384	0.000384	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IL1RN—osteoarthritis	0.000378	0.000378	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000376	0.000376	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—IL1A—osteoarthritis	0.000364	0.000364	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—IL1A—osteoarthritis	0.000363	0.000363	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—IL1A—osteoarthritis	0.000361	0.000361	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—BMP2—osteoarthritis	0.000359	0.000359	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—BMP2—osteoarthritis	0.000358	0.000358	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—BMP2—osteoarthritis	0.000356	0.000356	CbGpPWpGaD
Bortezomib—PSMA1—Gene Expression—SMAD3—osteoarthritis	0.000347	0.000347	CbGpPWpGaD
Bortezomib—PSMD1—Gene Expression—SMAD3—osteoarthritis	0.000345	0.000345	CbGpPWpGaD
Bortezomib—PSMD2—Gene Expression—SMAD3—osteoarthritis	0.000343	0.000343	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.000341	0.000341	CbGpPWpGaD
Bortezomib—PTGS1—Selenium Micronutrient Network—IL6—osteoarthritis	0.000341	0.000341	CbGpPWpGaD
Bortezomib—PSMA1—Disease—SMAD3—osteoarthritis	0.000322	0.000322	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000322	0.000322	CbGpPWpGaD
Bortezomib—PSMD1—Disease—SMAD3—osteoarthritis	0.00032	0.00032	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PTGES—osteoarthritis	0.000319	0.000319	CbGpPWpGaD
Bortezomib—PSMD2—Disease—SMAD3—osteoarthritis	0.000319	0.000319	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.000319	0.000319	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.000319	0.000319	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CRP—osteoarthritis	0.000305	0.000305	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CRP—osteoarthritis	0.000303	0.000303	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CRP—osteoarthritis	0.000302	0.000302	CbGpPWpGaD
Bortezomib—PSMA1—Gene Expression—ESR1—osteoarthritis	0.000283	0.000283	CbGpPWpGaD
Bortezomib—PSMD1—Gene Expression—ESR1—osteoarthritis	0.000282	0.000282	CbGpPWpGaD
Bortezomib—PSMD2—Gene Expression—ESR1—osteoarthritis	0.00028	0.00028	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IL1A—osteoarthritis	0.000276	0.000276	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IL1A—osteoarthritis	0.000276	0.000276	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL1A—osteoarthritis	0.000276	0.000276	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—FMOD—osteoarthritis	0.000276	0.000276	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—BMP2—osteoarthritis	0.000272	0.000272	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—BMP2—osteoarthritis	0.000272	0.000272	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—BMP2—osteoarthritis	0.000272	0.000272	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IL1A—osteoarthritis	0.000272	0.000272	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—BMP2—osteoarthritis	0.000269	0.000269	CbGpPWpGaD
Bortezomib—PSMB1—Gene Expression—SMAD3—osteoarthritis	0.000263	0.000263	CbGpPWpGaD
Bortezomib—PSMB5—Gene Expression—SMAD3—osteoarthritis	0.000263	0.000263	CbGpPWpGaD
Bortezomib—PSMB2—Gene Expression—SMAD3—osteoarthritis	0.000263	0.000263	CbGpPWpGaD
Bortezomib—PSMB8—Gene Expression—SMAD3—osteoarthritis	0.000259	0.000259	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—IL6—osteoarthritis	0.000255	0.000255	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—FMOD—osteoarthritis	0.000253	0.000253	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—MMP3—osteoarthritis	0.000249	0.000249	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—MMP3—osteoarthritis	0.000248	0.000248	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—MMP3—osteoarthritis	0.000247	0.000247	CbGpPWpGaD
Bortezomib—PSMB5—Disease—SMAD3—osteoarthritis	0.000244	0.000244	CbGpPWpGaD
Bortezomib—PSMB1—Disease—SMAD3—osteoarthritis	0.000244	0.000244	CbGpPWpGaD
Bortezomib—PSMB2—Disease—SMAD3—osteoarthritis	0.000244	0.000244	CbGpPWpGaD
Bortezomib—PSMB8—Disease—SMAD3—osteoarthritis	0.000241	0.000241	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CRP—osteoarthritis	0.000231	0.000231	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CRP—osteoarthritis	0.000231	0.000231	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CRP—osteoarthritis	0.000231	0.000231	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CRP—osteoarthritis	0.000228	0.000228	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—FMOD—osteoarthritis	0.000226	0.000226	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—SMAD3—osteoarthritis	0.000225	0.000225	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PTGES—osteoarthritis	0.000225	0.000225	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—GSTO1—osteoarthritis	0.000225	0.000225	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—SMAD3—osteoarthritis	0.000224	0.000224	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—SMAD3—osteoarthritis	0.000223	0.000223	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—BGN—osteoarthritis	0.000218	0.000218	CbGpPWpGaD
Bortezomib—PSMB5—Gene Expression—ESR1—osteoarthritis	0.000214	0.000214	CbGpPWpGaD
Bortezomib—PSMB1—Gene Expression—ESR1—osteoarthritis	0.000214	0.000214	CbGpPWpGaD
Bortezomib—PSMB2—Gene Expression—ESR1—osteoarthritis	0.000214	0.000214	CbGpPWpGaD
Bortezomib—PSMB8—Gene Expression—ESR1—osteoarthritis	0.000211	0.000211	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—FMOD—osteoarthritis	0.000207	0.000207	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTGES—osteoarthritis	0.000206	0.000206	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—FMOD—osteoarthritis	0.000206	0.000206	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—LEP—osteoarthritis	0.000193	0.000193	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—LEP—osteoarthritis	0.000192	0.000192	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—LEP—osteoarthritis	0.000191	0.000191	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—IL1B—osteoarthritis	0.00019	0.00019	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—IL1B—osteoarthritis	0.000189	0.000189	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—MMP3—osteoarthritis	0.000189	0.000189	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—MMP3—osteoarthritis	0.000189	0.000189	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—MMP3—osteoarthritis	0.000189	0.000189	CbGpPWpGaD
Bortezomib—PSMA1—Disease—PTGS2—osteoarthritis	0.000189	0.000189	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—IL1B—osteoarthritis	0.000188	0.000188	CbGpPWpGaD
Bortezomib—PSMD1—Disease—PTGS2—osteoarthritis	0.000188	0.000188	CbGpPWpGaD
Bortezomib—PSMD2—Disease—PTGS2—osteoarthritis	0.000187	0.000187	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—MMP3—osteoarthritis	0.000186	0.000186	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—ESR1—osteoarthritis	0.000184	0.000184	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTGES—osteoarthritis	0.000184	0.000184	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—ESR1—osteoarthritis	0.000183	0.000183	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—ESR1—osteoarthritis	0.000182	0.000182	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—FN1—osteoarthritis	0.000182	0.000182	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—FN1—osteoarthritis	0.000181	0.000181	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—FN1—osteoarthritis	0.00018	0.00018	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—FMOD—osteoarthritis	0.000176	0.000176	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—SMAD3—osteoarthritis	0.000171	0.000171	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—SMAD3—osteoarthritis	0.000171	0.000171	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—SMAD3—osteoarthritis	0.000171	0.000171	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTGES—osteoarthritis	0.000169	0.000169	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—SMAD3—osteoarthritis	0.000168	0.000168	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTGES—osteoarthritis	0.000168	0.000168	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—IGF1—osteoarthritis	0.000159	0.000159	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—IGF1—osteoarthritis	0.000158	0.000158	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—GSTO1—osteoarthritis	0.000158	0.000158	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—PTGS2—osteoarthritis	0.000158	0.000158	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—IGF1—osteoarthritis	0.000158	0.000158	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—PTGS2—osteoarthritis	0.000157	0.000157	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—PTGS2—osteoarthritis	0.000156	0.000156	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—BGN—osteoarthritis	0.000153	0.000153	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—LEP—osteoarthritis	0.000146	0.000146	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—LEP—osteoarthritis	0.000146	0.000146	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—LEP—osteoarthritis	0.000146	0.000146	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—GSTO1—osteoarthritis	0.000145	0.000145	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IL1B—osteoarthritis	0.000144	0.000144	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL1B—osteoarthritis	0.000144	0.000144	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IL1B—osteoarthritis	0.000144	0.000144	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—LEP—osteoarthritis	0.000144	0.000144	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTGES—osteoarthritis	0.000143	0.000143	CbGpPWpGaD
Bortezomib—PSMB1—Disease—PTGS2—osteoarthritis	0.000143	0.000143	CbGpPWpGaD
Bortezomib—PSMB2—Disease—PTGS2—osteoarthritis	0.000143	0.000143	CbGpPWpGaD
Bortezomib—PSMB5—Disease—PTGS2—osteoarthritis	0.000143	0.000143	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IL1B—osteoarthritis	0.000142	0.000142	CbGpPWpGaD
Bortezomib—PSMB8—Disease—PTGS2—osteoarthritis	0.000141	0.000141	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—BGN—osteoarthritis	0.000141	0.000141	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.00014	0.00014	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—ESR1—osteoarthritis	0.000139	0.000139	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—ESR1—osteoarthritis	0.000139	0.000139	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—ESR1—osteoarthritis	0.000139	0.000139	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—FN1—osteoarthritis	0.000138	0.000138	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—FN1—osteoarthritis	0.000138	0.000138	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—FN1—osteoarthritis	0.000138	0.000138	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—ESR1—osteoarthritis	0.000137	0.000137	CbGpPWpGaD
Bortezomib—PSMA1—Disease—TGFB1—osteoarthritis	0.000136	0.000136	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—FN1—osteoarthritis	0.000136	0.000136	CbGpPWpGaD
Bortezomib—PSMD1—Disease—TGFB1—osteoarthritis	0.000136	0.000136	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—FMOD—osteoarthritis	0.000136	0.000136	CbGpPWpGaD
Bortezomib—PSMD2—Disease—TGFB1—osteoarthritis	0.000135	0.000135	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GSTO1—osteoarthritis	0.00013	0.00013	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—CXCL8—osteoarthritis	0.000128	0.000128	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—CXCL8—osteoarthritis	0.000127	0.000127	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—CXCL8—osteoarthritis	0.000127	0.000127	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—BGN—osteoarthritis	0.000125	0.000125	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—IGF1—osteoarthritis	0.000121	0.000121	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—IGF1—osteoarthritis	0.000121	0.000121	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—IGF1—osteoarthritis	0.000121	0.000121	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—PTGS2—osteoarthritis	0.00012	0.00012	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—PTGS2—osteoarthritis	0.00012	0.00012	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—PTGS2—osteoarthritis	0.00012	0.00012	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GSTO1—osteoarthritis	0.000119	0.000119	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—IGF1—osteoarthritis	0.000119	0.000119	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GSTO1—osteoarthritis	0.000118	0.000118	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—PTGS2—osteoarthritis	0.000118	0.000118	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—MMP9—osteoarthritis	0.000116	0.000116	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—BGN—osteoarthritis	0.000115	0.000115	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—MMP9—osteoarthritis	0.000115	0.000115	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—MMP9—osteoarthritis	0.000115	0.000115	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—BGN—osteoarthritis	0.000114	0.000114	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—IL6—osteoarthritis	0.000111	0.000111	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—IL6—osteoarthritis	0.000111	0.000111	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTGES—osteoarthritis	0.000111	0.000111	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—IL6—osteoarthritis	0.00011	0.00011	CbGpPWpGaD
Bortezomib—PSMB5—Disease—TGFB1—osteoarthritis	0.000103	0.000103	CbGpPWpGaD
Bortezomib—PSMB2—Disease—TGFB1—osteoarthritis	0.000103	0.000103	CbGpPWpGaD
Bortezomib—PSMB1—Disease—TGFB1—osteoarthritis	0.000103	0.000103	CbGpPWpGaD
Bortezomib—PSMA1—Disease—IL6—osteoarthritis	0.000103	0.000103	CbGpPWpGaD
Bortezomib—PSMD1—Disease—IL6—osteoarthritis	0.000102	0.000102	CbGpPWpGaD
Bortezomib—PSMB8—Disease—TGFB1—osteoarthritis	0.000102	0.000102	CbGpPWpGaD
Bortezomib—PSMD2—Disease—IL6—osteoarthritis	0.000102	0.000102	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GSTO1—osteoarthritis	0.000101	0.000101	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	9.9e-05	9.9e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—BGN—osteoarthritis	9.78e-05	9.78e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CXCL8—osteoarthritis	9.7e-05	9.7e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CXCL8—osteoarthritis	9.7e-05	9.7e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—CXCL8—osteoarthritis	9.7e-05	9.7e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—CXCL8—osteoarthritis	9.57e-05	9.57e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—TGFB1—osteoarthritis	9.55e-05	9.55e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—TGFB1—osteoarthritis	9.5e-05	9.5e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—TGFB1—osteoarthritis	9.46e-05	9.46e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	9.07e-05	9.07e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—MMP9—osteoarthritis	8.78e-05	8.78e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—MMP9—osteoarthritis	8.78e-05	8.78e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—MMP9—osteoarthritis	8.78e-05	8.78e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—MMP9—osteoarthritis	8.65e-05	8.65e-05	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IL6—osteoarthritis	8.43e-05	8.43e-05	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL6—osteoarthritis	8.43e-05	8.43e-05	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IL6—osteoarthritis	8.43e-05	8.43e-05	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IL6—osteoarthritis	8.31e-05	8.31e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	8.1e-05	8.1e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GSTO1—osteoarthritis	7.79e-05	7.79e-05	CbGpPWpGaD
Bortezomib—PSMB5—Disease—IL6—osteoarthritis	7.78e-05	7.78e-05	CbGpPWpGaD
Bortezomib—PSMB1—Disease—IL6—osteoarthritis	7.78e-05	7.78e-05	CbGpPWpGaD
Bortezomib—PSMB2—Disease—IL6—osteoarthritis	7.78e-05	7.78e-05	CbGpPWpGaD
Bortezomib—PSMB8—Disease—IL6—osteoarthritis	7.67e-05	7.67e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—BGN—osteoarthritis	7.54e-05	7.54e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	7.38e-05	7.38e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TGFB1—osteoarthritis	7.23e-05	7.23e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TGFB1—osteoarthritis	7.23e-05	7.23e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TGFB1—osteoarthritis	7.23e-05	7.23e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—IL6—osteoarthritis	7.19e-05	7.19e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—IL6—osteoarthritis	7.16e-05	7.16e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TGFB1—osteoarthritis	7.13e-05	7.13e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—IL6—osteoarthritis	7.12e-05	7.12e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	6.31e-05	6.31e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PTGS2—osteoarthritis	6.26e-05	6.26e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—IL6—osteoarthritis	5.45e-05	5.45e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—IL6—osteoarthritis	5.45e-05	5.45e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—IL6—osteoarthritis	5.45e-05	5.45e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—IL6—osteoarthritis	5.37e-05	5.37e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PTGS2—osteoarthritis	4.41e-05	4.41e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTGS2—osteoarthritis	4.04e-05	4.04e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTGS2—osteoarthritis	3.61e-05	3.61e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTGS2—osteoarthritis	3.32e-05	3.32e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTGS2—osteoarthritis	3.29e-05	3.29e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTGS2—osteoarthritis	2.81e-05	2.81e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTGS2—osteoarthritis	2.17e-05	2.17e-05	CbGpPWpGaD
